Watch the new EASL Takeaway
Prof. William Alazawi, Prof. Luca Valenti and Prof. Rui Castro provide insights into the latest developments in the area of Metabolism, Alcohol and Toxicity in liver disease. The panel reviewed the therapeutic advances, focusing on cotadutide and MRI-PDFF ability to predict treatment response to resmetirom, and looked at a number of preclinical and clinical studies focused on the mechanisms underlying NASH and the development of a polygenic risk score for progressive NAFLD risk stratification.
 
Don't miss episode 2 of Highlights for patients on "COVID-19 and the liver"
Prof. Mojca Matičič provides an introduction to COVID-19, its symptoms and course, and the risk factors for severe disease. She is joined by Prof. Maria Buti, Prof. Antonio Craxì and Marko Korenjak for an overview of the latest findings on how COVID-19 interacts with liver disease.
Missed the previous EASL Takeaways?
Discover a series of expert discussions and debates around the major Digital ILC 2020 topics.
Save the date for the next EASL Takeaways
Discover the open-access Metabolism, Alcohol and Toxicity on EASL Campus
On EASL Campus you can find diverse open-access educational resources on Metabolisn, Alcohol and Toxicity. Here is a selection:
Create a free account or use your existing one and start learning from worldwide experts.
Digital International Liver Congress™ 2020 is now on-demand
Metabolism, Alcohol and Toxicity track at Digital ILC 2020
Access the on-demand content to discover the latest research comprising over 80 resources (videos, posters, abstract & interactive sessions, panel discussions, lectures, etc.).
Best of Digital ILC 2020 Slide Deck on Metabolism, Alcohol and Toxicity is available exclusively to Digital ILC 2020 registered delegates.
|
|
|
